| European Federation of Internal Medicine

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News

Type: News Feed

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 17 December 2025 - 15:46

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 1, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 22, Status: Authorised

Submitted by Anonymous (not verified) on 17 December 2025 - 15:45

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 22, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised

Submitted by Anonymous (not verified) on 17 December 2025 - 15:40

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Submitted by Anonymous (not verified) on 17 December 2025 - 15:30

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Read more about List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 17 December 2025 - 15:30

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 29, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 29, Status: Authorised

Medicine shortages and availability issues: guidance for companies

Submitted by Anonymous (not verified) on 17 December 2025 - 15:23

Medicine shortages and availability issues: guidance for companies

Read more about Medicine shortages and availability issues: guidance for companies

Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)

Submitted by Anonymous (not verified) on 17 December 2025 - 15:20

Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)

Read more about Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)

Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

Submitted by Anonymous (not verified) on 17 December 2025 - 15:19

Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

Read more about Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

Submitted by Anonymous (not verified) on 17 December 2025 - 15:16

Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

Read more about Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 29, Status: Authorised

Medicine shortages and availability issues: guidance for companies

Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)

Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report

Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters